BOC Sciences Completed Deployment of GMP Manufacturing Facilities to Promote Drug R&D

Recently, BOC Sciences announced that it has completed the commissioning of its new GMP platform.

Recently, the world's leading pharmaceutical product developer and GMP manufacturer, BOC Sciences, announced that it has completed the commissioning of its new GMP platform to produce screening compounds, starting materials, structural units, intermediates, lead compound derivatives, nucleosides, nucleotides, small molecules, active pharmaceutical ingredients (API) and peptides that meet GMP standards.

The new cGMP manufacturing platform aims to achieve scale flexibility, which can realize routine monitoring of temperature, pressure, humidity, and particle count, and the platform is equipped with ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients) cleanrooms, ICH Q8 cleanrooms, and two analytical and functional support laboratories to support product testing. As Anna Green, the project manager of BOC Sciences, said, “Our optimized cGMP platform is supported by a comprehensive quality plan and quality system, which can help offer a series of products and services for customers who have strictly defined specifications to control the manufacturing process.”

Undoubtedly, this move further strengthens BOC Sciences’s ability to provide drug discovery services, including medicinal chemistry, custom synthesis, analysis/purification, formulation services. The compounds produced by BOC Sciences's GMP business unit can meet any defined specifications, and customers can fully control the entire process. All products have guaranteed stability and batch retention, and are produced in dedicated cleanroom equipment to eliminate potential pollution, and each order is strictly QC and HPLC purified.

Anna said, "From intermediate to API and from chemical drugs to macromolecules, all products are manufactured in compliance with ICH guidelines. Our GMP manufacturing service provides faster development, higher yield, and better quality, reduced batch-to-batch variability, better scalability, and lower production costs. "

About BOC Sciences
BOC Sciences, a brand of BOCSCI Inc, leverages its wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to meet the evolving needs of customers for premium chemicals. BOC Sciences has the most advanced and the latest "Good Manufacturing Practices" (cGMP) production facilities. Its unparalleled experience, technical expertise, and scalability make BOC Sciences an ideal partner for clinical or pre-clinical projects. From the initial research to the production of APIs for clinical trials, BOC Sciences can support various related projects. For more information about BOC Sciences products, please visit

Contact Info:
Name: Alex Brown
Email: Send Email
Organization: BOC Sciences

Release ID: 89023302